Quarterly Results

202602 Results Summary

Revenue

The revenue stands at ₹ crore, reflecting a quarter-on-quarter *(QoQ) decrease of per cent from ₹ crore. This corresponds to a year-on-year *(YoY) decline of per cent.

Operating Profit

Operating Profit stands at ₹ crore, reflecting a quarter-on-quarter *(QoQ) decrease of per cent from ₹ crore. This corresponds to a year-on-year *(YoY) decline of per cent.

PBDT

PBDT stands at ₹ crore, reflecting a quarter-on-quarter *(QoQ) decrease of per cent from ₹ crore. This corresponds to a year-on-year *(YoY) decline of per cent.

Profit Before Tax

Profit Before Tax stands at ₹ crore, reflecting a quarter-on-quarter *(QoQ) decrease of per cent from ₹ crore. This corresponds to a year-on-year *(YoY) decline of per cent.

Net Profit

Net Profit stands at ₹ crore, reflecting a quarter-on-quarter *(QoQ) decrease of per cent from ₹ crore. This represents a per cent year-on-year *(YoY) decline for the same year.

YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.

Company News

Earnings

YOY

QOQ

Category	Q3 FY25-26	Q3 FY24-25	Change %	FY24-25	FY23-24	Change %
Total Revenue	1,374.84	1,146.13	19.95	4,648.10	4,208.71	10.44
Expenses	992.60	825.30	20.27	3,388.60	3,036.77	11.59
Other Income	24.97	30.44	-17.97	94.50	84.60	11.70
Operating Profit	30.07	38.35	-21.59	1,354.00	1,256.54	7.76
Depreciation	43.51	35.97	20.96	144.11	135.40	6.43
Interest	5.10	7.91	-35.52	20.73	7.21	187.52
Profit Before Tax	358.60	307.39	16.66	1,189.16	1,113.93	6.75
Tax	84.83	74.51	13.85	312.30	322.06	-3.03
Net Profit	273.77	232.88	17.56	920.39	816.17	12.77

Category	Q3 FY25-26	Q3 FY24-25	Change %	FY24-25	FY23-24	Change %
Total Revenue	1,206.59	1,101.92	9.50	4,322.04	3,971.12	8.84
Expenses	865.64	765.59	13.07	3,117.32	2,851.69	9.31
Other Income	25.76	33.23	-22.48	119.87	116.48	2.91
Operating Profit	927.60	869.64	6.66	1,324.59	1,235.91	7.18
Depreciation	42.38	34.93	21.33	139.93	132.16	5.88
Interest	1.87	2.48	-24.60	4.60	6.80	-32.35
Profit Before Tax	322.46	332.15	-2.92	1,180.06	1,096.95	7.58
Tax	77.42	79.70	-2.86	258.03	277.58	-7.04
Net Profit	245.04	252.45	-2.94	916.89	807.24	13.58

Category	Q3 FY25-26	Q2 FY25-26	Change %
Total Revenue	1,374.84	1,353.73	1.56
Expenses	992.60	1,025.90	-3.25
Other Income	24.97	59.34	-57.92
Operating Profit	30.07	62.73	-52.06
Depreciation	43.51	42.97	1.26
Interest	5.10	3.39	50.44
Profit Before Tax	358.60	340.81	5.22
Tax	84.83	80.62	5.22
Net Profit	273.77	260.19	5.22

Category	Q3 FY25-26	Q2 FY25-26	Change %
Total Revenue	1,206.59	1,220.24	-1.12
Expenses	865.64	930.65	-6.99
Other Income	25.76	75.03	-65.67
Operating Profit	927.60	951.94	-2.56
Depreciation	42.38	41.92	1.10
Interest	1.87	0.73	156.16
Profit Before Tax	322.46	321.97	0.15
Tax	77.42	72.44	6.87
Net Profit	245.04	249.53	-1.80

Research Reports

Action	Target Price (₹)	Broker	Date	Reports
Data Not Found

Financial Reports

Data not available.

Stock Prices Compare with Peers

Company	1 Day	1 Week	1 Month	3 Months	6 Month	1 Year
Data Not Found

Corporate Information

Company News

Tariff relief buzz lifts Nifty Pharma Index; Lupin, Aurobindo lead gains

Pharma stocks were rising in trade today as export concerns eased on US tariff report. Check out the top stocks that may benefit from US tariff relief

Updated On: 09 Oct 2025 | 11:02 AM IST

Ajanta Pharma newly rated 'Buy' at PL Capital; 26% upside seen; check TP

The brokerage analysis suggested that branded generics contributed to 74 per cent of Ajanta Pharma's revenue in FY25 and its branded generics business operates with a healthy OPM of 30 per cent

Updated On: 24 Sep 2025 | 8:35 AM IST